To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Healthy
Interventions
DRUG

PF-05186462

single intravenous infusion of 100 microgram

DRUG

PF-05186462

single oral administration of 100 microgram

DRUG

PF-05089771

single intravenous infusion of 100 microgram of PF-05089771

DRUG

PF-05089771

single oral administration of 100 microgram PF-05089771

DRUG

PF-05150122

single intravenous administration of 100 microgram PF-05150122

DRUG

PF-05150122

single oral administration of 100 microgram PF-05150122

DRUG

PF-05241328

single intravenous infusion of 100 microgram PF-05241328

DRUG

PF-05241328

single oral administration 100 microgram PF-05241328

Trial Locations (1)

EH14 4AP

Pfizer Investigational Site, Edinburgh

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY